Studies by others have found that metformin suppressed inflammation in diabetic nephropathy by inhibiting H19 expression and that dihydroartemisinin inhibited the development of liver fibrosis (Xu et al., 2020; Xia et al., 2021). This evidence concerns the gene H19 and Hepatic fibrosis.